| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1168 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 937 | 2022 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 770 | 2021 |
| Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing DW Eyre, ML Cule, DJ Wilson, D Griffiths, A Vaughan, L O'Connor, CLC Ip, ... New England Journal of Medicine 369 (13), 1195-1205, 2013 | 758 | 2013 |
| Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis P Bradley, NC Gordon, TM Walker, L Dunn, S Heys, B Huang, S Earle, ... Nature communications 6 (1), 10063, 2015 | 636 | 2015 |
| Multilocus Sequence Typing of Clostridium difficile D Griffiths, W Fawley, M Kachrimanidou, R Bowden, DW Crook, R Fung, ... Journal of clinical microbiology 48 (3), 770-778, 2010 | 511 | 2010 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 479 | 2021 |
| SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), 2021 | 405* | 2021 |
| Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing NC Gordon, JR Price, K Cole, R Everitt, M Morgan, J Finney, AM Kearns, ... Journal of clinical microbiology 52 (4), 1182-1191, 2014 | 393 | 2014 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 365 | 2021 |
| Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing CRyPTIC Consortium and the 100,000 Genomes Project New England Journal of Medicine 379 (15), 1403-1415, 2018 | 360 | 2018 |
| Effects of control interventions on Clostridium difficile infection in England: an observational study KE Dingle, X Didelot, TP Quan, DW Eyre, N Stoesser, T Golubchik, ... The Lancet Infectious Diseases 17 (4), 411-421, 2017 | 331 | 2017 |
| Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease BC Young, T Golubchik, EM Batty, R Fung, H Larner-Svensson, ... Proceedings of the National Academy of Sciences 109 (12), 4550-4555, 2012 | 330 | 2012 |
| A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance DW Eyre, T Golubchik, NC Gordon, R Bowden, P Piazza, EM Batty, ... BMJ open 2 (3), e001124, 2012 | 303 | 2012 |
| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 269 | 2020 |
| Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study TM Walker, MK Lalor, A Broda, LS Ortega, M Morgan, L Parker, ... The Lancet Respiratory Medicine 2 (4), 285-292, 2014 | 251 | 2014 |
| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity COMBATC Consortium Cell 185 (5), 916-938.e58, 2022 | 242 | 2022 |
| Within-host evolution of Staphylococcus aureus during asymptomatic carriage T Golubchik, EM Batty, RR Miller, H Farr, BC Young, H Larner-Svensson, ... PloS one 8 (5), e61319, 2013 | 242 | 2013 |
| Microevolutionary analysis of Clostridium difficile genomes to investigate transmission X Didelot, DW Eyre, M Cule, CLC Ip, MA Ansari, D Griffiths, A Vaughan, ... Genome biology 13, 1-13, 2012 | 238 | 2012 |
| Evolutionary History of the Clostridium difficile Pathogenicity Locus KE Dingle, B Elliott, E Robinson, D Griffiths, DW Eyre, N Stoesser, ... Genome biology and evolution 6 (1), 36-52, 2014 | 202 | 2014 |
Rory BowdenWalter and Eliza Hall Institute of Medical ResearchZweryfikowany adres z wehi.edu.au
